Defining human mesenchymal stem cell efficacy <it>in vivo</it>
<p>Abstract</p> <p>Allogeneic human mesenchymal stem cells (hMSCs) can suppress graft versus host disease (GvHD) and have profound anti-inflammatory and regenerative capacity in stroke, infarct, spinal cord injury, meniscus regeneration, tendinitis, acute renal failure, and heart d...
Saved in:
Main Authors: | Lennon Donald P (Author), Nolan (Koloze) (Author), Bonfield Tracey L (Author), Caplan Arnold I (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2010-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chronic asthma and Mesenchymal stem cells: Hyaluronan and airway remodeling
by: Benjamin D. Goldstein, et al.
Published: (2017) -
Adult Mesenchymal Stem Cells: When, Where, and How
by: Arnold I. Caplan
Published: (2015) -
Antimicrobial Properties of Mesenchymal Stem Cells: Therapeutic Potential for Cystic Fibrosis Infection, and Treatment
by: Morgan T. Sutton, et al.
Published: (2016) -
Ex Vivo Expansion of Human Mesenchymal Stem Cells in Defined Serum-Free Media
by: Sunghoon Jung, et al.
Published: (2012) -
Human Mesenchymal Stem Cell (hMSC) Donor Potency Selection for the "First in Cystic Fibrosis" Phase I Clinical Trial (CEASE-CF)
by: Tracey L. Bonfield, et al.
Published: (2023)